Try our beta test site
Trial record 1 of 1 for:    NCT01555268
Previous Study | Return to List | Next Study

Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Amgen
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01555268
First received: February 16, 2012
Last updated: February 14, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 3, 2016
  Primary Completion Date: September 24, 2013 (Final data collection date for primary outcome measure)